16-78970332-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016373.4(WWOX):​c.1057-241276T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.645 in 152,082 control chromosomes in the GnomAD database, including 31,886 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.64 ( 31886 hom., cov: 33)

Consequence

WWOX
NM_016373.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.00100

Publications

5 publications found
Variant links:
Genes affected
WWOX (HGNC:12799): (WW domain containing oxidoreductase) This gene encodes a member of the short-chain dehydrogenases/reductases (SDR) protein family. This gene spans the FRA16D common chromosomal fragile site and appears to function as a tumor suppressor gene. Expression of the encoded protein is able to induce apoptosis, while defects in this gene are associated with multiple types of cancer. Disruption of this gene is also associated with autosomal recessive spinocerebellar ataxia 12. Disruption of a similar gene in mouse results in impaired steroidogenesis, additionally suggesting a metabolic function for the protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
WWOX Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive spinocerebellar ataxia 12
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
  • developmental and epileptic encephalopathy, 28
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • 46,XY partial gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.711 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016373.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WWOX
NM_016373.4
MANE Select
c.1057-241276T>C
intron
N/ANP_057457.1Q9NZC7-1
WWOX
NM_001291997.2
c.718-241276T>C
intron
N/ANP_001278926.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WWOX
ENST00000566780.6
TSL:1 MANE Select
c.1057-241276T>C
intron
N/AENSP00000457230.1Q9NZC7-1
WWOX
ENST00000402655.6
TSL:1
c.410-241276T>C
intron
N/AENSP00000384238.2Q9NZC7-6
WWOX
ENST00000406884.6
TSL:1
c.517-241276T>C
intron
N/AENSP00000384495.2Q9NZC7-5

Frequencies

GnomAD3 genomes
AF:
0.645
AC:
97985
AN:
151964
Hom.:
31866
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.718
Gnomad AMI
AF:
0.659
Gnomad AMR
AF:
0.621
Gnomad ASJ
AF:
0.593
Gnomad EAS
AF:
0.479
Gnomad SAS
AF:
0.605
Gnomad FIN
AF:
0.612
Gnomad MID
AF:
0.614
Gnomad NFE
AF:
0.629
Gnomad OTH
AF:
0.638
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.645
AC:
98055
AN:
152082
Hom.:
31886
Cov.:
33
AF XY:
0.641
AC XY:
47680
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.718
AC:
29792
AN:
41506
American (AMR)
AF:
0.621
AC:
9483
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.593
AC:
2056
AN:
3466
East Asian (EAS)
AF:
0.479
AC:
2470
AN:
5158
South Asian (SAS)
AF:
0.606
AC:
2912
AN:
4806
European-Finnish (FIN)
AF:
0.612
AC:
6464
AN:
10564
Middle Eastern (MID)
AF:
0.616
AC:
181
AN:
294
European-Non Finnish (NFE)
AF:
0.629
AC:
42764
AN:
67998
Other (OTH)
AF:
0.632
AC:
1335
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1810
3620
5430
7240
9050
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
788
1576
2364
3152
3940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.630
Hom.:
124534
Bravo
AF:
0.646
Asia WGS
AF:
0.544
AC:
1894
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.8
DANN
Benign
0.72
PhyloP100
-0.0010
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12716865; hg19: chr16-79004229; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.